49.02
-0.01 (-0.02%)
| Previous Close | 49.03 |
| Open | 49.70 |
| Volume | 273,030 |
| Avg. Volume (3M) | 709,050 |
| Market Cap | 2,322,183,680 |
| Price / Earnings (TTM) | 12.54 |
| Price / Earnings (Forward) | 10.92 |
| Price / Sales | 2.19 |
| Price / Book | 1.23 |
| 52 Weeks Range | |
| Earnings Date | 6 Aug 2026 |
| Profit Margin | 18.86% |
| Operating Margin (TTM) | 34.03% |
| Diluted EPS (TTM) | 4.29 |
| Quarterly Revenue Growth (YOY) | 7.10% |
| Quarterly Earnings Growth (YOY) | 1.40% |
| Total Debt/Equity (MRQ) | 56.91% |
| Current Ratio (MRQ) | 4.20 |
| Operating Cash Flow (TTM) | 251.52 M |
| Levered Free Cash Flow (TTM) | 188.69 M |
| Return on Assets (TTM) | 6.50% |
| Return on Equity (TTM) | 12.30% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Mixed | Bullish |
| Drug Manufacturers - Specialty & Generic (Global) | Mixed | Mixed | |
| Stock | Prestige Consumer Healthcare In | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | 1.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 2.0 |
| Average | 2.00 |
|
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige’s key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer’s Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Value |
| % Held by Insiders | 1.23% |
| % Held by Institutions | 108.15% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |